ISLB 2023


Navneet Singh

Navneet Singh: India
Categories: Invited Speakers
Dr. Navneet Singh MD DM is a thoracic medical oncologist and tenured (full) Professor of Pulmonary Medicine at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Prof. Singh is the coordinator-cum-convener for PGIMER’s multidisciplinary thoracic oncology group that received the Lung Cancer Care Team Award of the International Association for Study of Lung Cancer (IASLC) at its 20th World Conference on Lung Cancer (WCLC) in Barcelona, Spain [2019].
Dr. Singh has been elected fellow of Royal College of Physicians (London), American College of Physicians (FACP), American College of Chest Physicians (FCCP) and Indian Chest Society. He has served as a reviewer for several international journals including New England Journal of Medicine and the Lancet group. He has 200+ publications in peer reviewed medical journals, authored several chapters in books and is an invited faculty and program committee member for IASLC’s annual WCLC. He is /has been member of IASLC’s Staging and Prognostic Factors Committee; Education-; Membership- and Publications- Committees as well.
A past recipient of the International Development & Education Award (IDEA) of American Society of Clinical Oncology (ASCO), Prof. Singh served as Chair of ASCO’s IDEA steering group (2018-20) and is currently Co-Chair of ASCO’s expert panel responsible for ‘living’ guideline on systemic therapy for stage IV NSCLC. Previously, he has been an invited member of ASCO’s special awards selection committee and thoracic cancer guideline group including expert panels that developed clinical practice guidelines on A) Molecular Biomarker Testing in advanced/metastatic NSCLC; B) Surveillance after curative-intent treatment of lung cancer; C) Systemic therapy for stage-IV NSCLC; D) Management of stage III NSCLC (co-chair) all being published in ASCO’s flagship Journal of Clinical Oncology.
Dr. Singh has been a recipient of several awards and honors for his contribution in the area of lung cancer including American Association of Cancer Research-National Cancer Institute (AACR-NCI) International Investigator Opportunity Grant (2009); European Society for Medical Oncology’s (ESMO)’s Translational Research Unit Visit (2010) and Palliative Care (2012-13) Fellowships; Kamal Satbir Award of the Indian Council for Medical Research (ICMR; 2014) and ISSLC’s Oration on Lung Cancer (2017) in addition to travel grants for several international meetings. Very recently, he has been chosen to be conferred with the Fellowship of ASCO (FASCO).